← Browse by Condition
Medical Condition

diabetic foot

Total Trials
3
Recruiting Now
3
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for diabetic foot sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — diabetic foot Clinical Trials

How many clinical trials are currently recruiting for diabetic foot?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for diabetic foot, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for diabetic foot?
diabetic foot research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a diabetic foot clinical trial?
Eligibility criteria for diabetic foot trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
EndoCore Lab s.r.l. 1 trial
Reprise Biomedical, Inc. 1 trial
Axolotl Biologix 1 trial

Recruiting Clinical Trials

NCT06277362
Recruiting
Peripheral Extreme Revascularization in "No-option" Patiens With Chronic Limb Threatening Ischemia
Enrollment
50 pts
Location
Italy
Sponsor
EndoCore Lab s.r.l.
View Trial →
NCT07632001
Recruiting
Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers
Enrollment
180 pts
Location
United States
Sponsor
Reprise Biomedical, Inc.
View Trial →
NCT06550596
Recruiting
Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers
Enrollment
100 pts
Location
United States
Sponsor
Axolotl Biologix
View Trial →

Related Conditions

peripheral arterial disease (1) critical limb threatening ischemia (1) diabetic foot ulcers dfus (1) chronic wounds (1) ulcer foot (1) foot ulcer (1) diabetic foot ulcer (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology